To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
To Characterize the Safety and Tolerability of Eculizumab in Two Japanese aHUS Patients
This protocol is intended to formally collect data on the treatment of aHUS with eculizumab
 in Japanese patients.
Inclusion Criteria:

 1. Patient and/or legal guardian must be willing and able to give written informed
 consent and id the patient is not an adult and able to read and write, the patient is
 willing to give written informed assent

 2. Eculizumab treatment initiated as personal importation for aHUS in 201

 Exclusion Criteria:

 Not Applicable